AorTech International (AOR) Share Price, News & Analysis

Company Overview

AorTech International plc, together with its subsidiaries, focuses on the commercialization of its biomedical polymer technology, components, and medical devices in the United Kingdom. The company offers Elast-Eon, a bio stable polyurethane material used in long term implantation; and Elast-Eon Carbonate Silicone, a family of biomedical polymers for applications in cardiac pacing leads, orthopedics, and spinal discs, as well as in other applications where the device requires a high level of mechanical performance. It also provides Elast-Eon Reaction Injection Molding products for use in high-precision medical device components. In addition, the company licenses its technology; and offers support services to other medical device companies. AorTech International plc was incorporated in 1996 and is headquartered in Weybridge, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 7,419 shs
• Average Volume: 40,686 shs
• Market Capitalization: £19.99 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AOR Stock Analysis - Frequently Asked Questions

How do I buy shares of AorTech International?

Shares of AOR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of AorTech International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that AorTech International investors own include KAZ Minerals (KAZ), Standard Chartered (STAN), Ascential (ASCL), Empyrean Energy (EME), Lloyds Banking Group (LYG), Meta Platforms (META) and Starbucks (SBUX).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:AOR
• CIK: N/A
• Web: www.aortech.net
• Phone: +44-1932-252123
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 32.06
• Quick Ratio: 32.06

Sales & Book Value

• Annual Sales: £539 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 8.33
• Book Value: GBX 19.40 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 16,186,600
• Free Float: N/A
• Market Cap: £19.99 million
• Optionable: Not Optionable
• Beta: N/A